Bristol-Myers Squibb Co  

(Public, OTCMKTS:BMYMP)   Watch this stock  
Find more results for NYSE:BMY-
0.00 (0.00%)
Delayed:   9:30AM EDT
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range     -
52 week 991.88 - 1,231.90
Open     -
Vol / Avg. 0.00/0.00
Mkt cap 127.65B
P/E 1,315.98
Div/yield 0.38/0.12
EPS 0.94
Shares 4,161.00
Beta -30.82
Inst. own 29920778%
Jul 28, 2016
Q2 2016 Bristol-Myers Squibb Co Earnings Call
Jul 28, 2016
Q2 2016 Bristol-Myers Squibb Co Earnings Release
Jun 7, 2016
Bristol-Myers Squibb Co at Goldman Sachs Global Healthcare Conference
Jun 4, 2016
Bristol-Myers Squibb Co to Discuss ASCO Highlights
May 4, 2016
Bristol-Myers Squibb Co at Deutsche Bank Health Care Conference
May 4, 2016
Bristol-Myers Squibb Co Annual Shareholders Meeting (Estimated)
May 3, 2016
Bristol-Myers Squibb Co Annual Shareholders Meeting

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin 27.47% 9.85%
Operating margin 37.58% 8.57%
EBITD margin - 16.27%
Return on average assets 15.20% 4.98%
Return on average equity 33.46% 10.75%
Employees 25,000 -
CDP Score - 100 C


NEW YORK, NY 10154
United States - Map
+1-212-5464000 (Phone)
+1-302-6555049 (Fax)

Website links

External links

About Company - Wikipedia


Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company's pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. It offers products for a range of therapeutic classes, which include virology, including human immunodeficiency virus (HIV) infection; oncology; immunoscience; cardiovascular, and neuroscience. Its late-stage investigational compounds that are in Phase III clinical trials include Beclabuvir, BMS-663068 and Prostvac.

Officers and directors

Giovanni Caforio M.D. Chief Executive Officer, Director
Age: 51
Charles A. Bancroft Chief Financial Officer, Executive Vice President
Age: 56
Louis S. Schmukler President - Global Manufacturing and Supply
Age: 60
Francis M. Cuss Executive Vice President, Chief Scientific Officer
Age: 61
Sandra Leung Executive Vice President, General Counsel and Corporate Secretary
Age: 55
Trading Activity - Yahoo Finance
Murdo Gordon Executive Vice President, Chief Commercial Officer
Age: 50
Paul von Autenried Senior Vice President - Enterprise Services, Chief Information Officer
Age: 54
Anne Nielsen Senior Vice President, Chief Compliance and Ethics Officer
Age: 55
Joseph C. Caldarella Senior Vice President, Corporate Controller
Age: 60
Trading Activity - Yahoo Finance
Ann Powell Judge Senior Vice President - Global Human Resources
Age: 50